Clinical Research Directory

Inclusion Criteria: 1. Patient between the age of 18 and 45 years 2. Patient is at least 6 months post-solid-organ transplant and has not received GARDASIL 9. 3. Patient who can participate in their health care and sign informed consent. 4. Patient may have had bivalent or quadrivalent HPV vaccination previously. 5. Living or deceased donor transplant patient is eligible. Exclusion Criteria: 6. Contraindication: Hypersensitivity, including severe allergic reactions to yeast (a vaccine component), or after a previous dose of GARDASIL 9 or GARDASIL. 7. Patient had completed vaccination series with a nonavalent HPV vaccine (e.g., GARDASIL 9) in the past 8. Patient with a diagnosis of HIV. 9. Patient that endorses being currently pregnant.